Zhejiang provincial traditional Chinese medicine li injection in the United States allowed Ⅲ stage of clinical trials

Zhejiang provincial traditional Chinese medicine li injection in the United States allowed Ⅲ stage of clinical trials

Release date: 2015-07-20 13:25:46

Source: the news

Recently, by zhejiang university of Chinese medicine research and development with independent intellectual property rights of anti-cancer traditional Chinese medicine (TCM) - li injection, to complete a phase II clinical trial of treatment of pancreatic cancer in the United States, and approved by the us food and drug administration (FDA) review through, enters the stage III expanding clinical trials, expanding use in patients with cancer in the United States. If through the phase III clinical trials, li allowed to enter the American market is expected to become the first one of traditional Chinese medicine injection. This is a breakthrough of traditional Chinese medicine and research in our country, and is also a new milestone of Chinese medicine to world.

Li injection by the Chinese academy of engineering, zhejiang university of traditional Chinese medicine scientific research team, led by professor da-peng li lasted 20 years, using international advanced technology such as supercritical carbon dioxide extraction, extracted from traditional Chinese medicine semen coicis effective anticancer active material, using the modern international cutting-edge production technology development. High-dose injection for arterial and venous infusion, can effectively prevent deterioration super-strength, prolong life. Clinical trials found that injection of middle or late have obvious effect of pancreatic cancer, lung cancer and liver cancer, combined radiation and chemotherapy, can be attenuated synergies.

Obtains the national new drug certificate in 1995, li injection, the study has been the state administration of traditional Chinese medicine, ministry of science and technology such as listed in the ">", "five-year", "five-year", "15" major science and technology research project, "li injection America ii, phase iii" as the national "11th five-year plan" major drug discovery projects has passed the acceptance. American science, points out that li is the Chinese herbal medicine of ephedrine, artemisinin, another proprietary representative results.